Elucidation of molecular mechanisms and functional significance of cooperation between glucocorticoid receptor and NF-kB in the airways
阐明气道中糖皮质激素受体与 NF-kB 合作的分子机制和功能意义
基本信息
- 批准号:9259045
- 负责人:
- 金额:$ 5.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adrenal Cortex HormonesAdverse effectsAllergensAmericanAnti-Inflammatory AgentsAnti-inflammatoryAsthmaAttenuatedBindingBinding SitesBiological AssayCell NucleusCellsChIP-seqChromatinChromatin LoopChronicChronic Obstructive Airway DiseaseChymaseClinicClustered Regularly Interspaced Short Palindromic RepeatsCytokine SuppressionDNA SequenceDataDiseaseDrug DesignElementsEnhancersEnzyme-Linked Immunosorbent AssayEpithelial CellsExtrinsic asthmaFeedbackGene ActivationGene ExpressionGene TargetingGenesGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGoalsImageryInfectionInflammatoryIntranasal AdministrationLightLiquid substanceLungManuscriptsMediatingMicroscopicModelingMolecularMucinsMusNF-kappa BNuclear ReceptorsPathway interactionsPatientsPharmaceutical PreparationsPropertyProtease InhibitorProteinsQuantitative Reverse Transcriptase PCRReporterRepressionRoleSite-Directed MutagenesisStaining methodStainsStructure of parenchyma of lungTechniquesTestingTherapeuticTreatment EfficacyWestern BlottingWorkairway epitheliumairway hyperresponsivenessairway inflammationairway remodelingallergic airway diseaseallergic airway inflammationbasecell typechromosome conformation capturecytokinegenome-wide analysisglucocorticoid receptor alphaglucocorticoid-induced orphan receptorimprovedin vivoinflammatory markermethacholinemouse modelnew therapeutic targetnovelnovel therapeuticsoverexpressionpromoterreceptor bindingsteroid hormonetranscription factor
项目摘要
Abstract
Corticosteroids or glucocorticoids (GCs) are widely used to treat inflammatory airway diseases such as
asthma. Despite their widespread use in the clinic, the molecular mechanisms underlying the therapeutic
actions of GCs remain incompletely understood. Glucocorticoids mediate their actions by binding to the
glucocorticoid receptor (GR) a nuclear receptor, which then translocates to the nucleus and regulates gene
expression. Anti-inflammatory actions of GR have classically been attributed to GR binding to other
transcription factors such as NF-KB and repressing their transcriptional activity while activation of gene
expression by GR has been implicated in the side effects of GCs. Recent studies, however, have shown that
GR can cooperate with NF-kB to activate gene expression. Indeed, our ChIP-Seq studies identified numerous
genes that are regulated cooperatively by GR and NF-kB in the airway epithelium. In addition, some of these
cooperatively activated genes have known anti-inflammatory actions that are glucocorticoid-independent.
Based on this evidence, we hypothesize that GR and NF-kB cooperate to induce anti-inflammatory gene
expression that contributes to therapeutic actions of GCs in airway epithelium. We will test our hypothesis by
interrogating the mechanism of cooperation between GR and NF-kB to induce SERPINA3 and by elucidating
the role of SERPINA3 in allergic airway inflammation. Our specific aims are 1) Identify and define the role of
key DNA sequence elements mediating GR and NF-kB cooperation at a putative SERPINA3 enhancer and 2)
Determine if SERPINA3 suppresses allergic airway inflammation in vivo. Through these aims we expect to
demonstrate that GR and NFkB cooperation represents a novel pathway underpinning the therapeutic actions
of GCs in inflammatory airway diseases.
摘要
皮质类固醇或糖皮质激素(GC)广泛用于治疗炎性气道疾病,例如
哮喘尽管它们在临床上广泛使用,但治疗性抗肿瘤的分子机制仍不清楚。
GC的作用仍然不完全清楚。糖皮质激素通过与糖皮质激素结合来介导其作用。
糖皮质激素受体(GR)是一种核受体,然后易位到细胞核并调节基因表达。
表情GR的抗炎作用经典地归因于GR与其他炎症因子的结合。
转录因子如NF-κ B,并在基因激活的同时抑制其转录活性
GR的表达与GC的副作用有关。然而,最近的研究表明,
GR可与NF-κ B协同激活基因表达。事实上,我们的ChIP-Seq研究发现了许多
在气道上皮中由GR和NF-kB协同调节的基因。此外,其中一些
协同激活的基因具有已知的不依赖糖皮质激素的抗炎作用。
基于这些证据,我们推测GR和NF-κ B协同诱导抗炎基因表达,
在气道上皮中,GCs的表达有助于GCs的治疗作用。我们将测试我们的假设,
探讨GR和NF-κ B协同诱导SERPINA 3的机制,
SERPINA 3在过敏性气道炎症中的作用我们的具体目标是:(1)确定和界定
在推定的SERPINA 3增强子处介导GR和NF-kB合作的关键DNA序列元件和2)
确定SERPINA 3是否抑制体内过敏性气道炎症。通过这些目标,我们希望
表明GR和NFkB的合作代表了支持治疗作用的新途径,
GC在炎症性气道疾病中的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vineela Kadiyala其他文献
Vineela Kadiyala的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 5.92万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 5.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 5.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 5.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 5.92万 - 项目类别:
Discovery Grants Program - Individual